Position history for JACOBS LEVY EQUITY MANAGEMENT, INC's holdings in Protagonist Therapeutics Inc
JACOBS LEVY EQUITY MANAGEMENT, INC previously held 0 shares of PTGX (Protagonist Therapeutics Inc), worth $0 as of 2025-Q2.
Final Value
$0
Final Shares
0
Total Value Change
-$4.5M
Total Shares Change
-129,011
Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT LLC, UBS Group AG
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $55.69 |
0 |
| 2025-Q1 | Unchanged | 128,654 | 0.0% | $6.2M | 0.0% | $48.88 | 0 |
| 2024-Q4 | Unchanged | 128,654 | 0.0% | $5M | 0.0% | $38.51 | 0 |
| 2024-Q3 | Decreased | 128,654 | -0.3% | $5.8M | 0.0% | $44.56 | 0 |
| 2024-Q2 | Unchanged | 129,011 | 0.0% | $4.5M | 0.0% | $34.65 | 0 |